Q1 EPS Forecast for U.S. Physical Therapy Lowered by Analyst

U.S. Physical Therapy, Inc. (NYSE:USPH) – Stock analysts at William Blair lowered their Q1 2025 EPS estimates for U.S. Physical Therapy in a research report issued on Tuesday, March 11th. William Blair analyst J. Haase now expects that the company will earn $0.48 per share for the quarter, down from their previous estimate of $0.56. William Blair currently has a “Market Perform” rating on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. William Blair also issued estimates for U.S. Physical Therapy’s Q2 2025 earnings at $0.71 EPS, Q3 2025 earnings at $0.77 EPS, Q4 2025 earnings at $0.76 EPS, FY2025 earnings at $2.73 EPS and FY2026 earnings at $3.05 EPS.

USPH has been the subject of a number of other reports. Citizens Jmp upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. JPMorgan Chase & Co. upped their price objective on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Tuesday, December 3rd. JMP Securities began coverage on shares of U.S. Physical Therapy in a research report on Monday, December 16th. They set an “outperform” rating and a $113.00 price target on the stock. Barrington Research dropped their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a research report on Friday, February 28th. Finally, StockNews.com cut U.S. Physical Therapy from a “hold” rating to a “sell” rating in a report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $111.50.

U.S. Physical Therapy Trading Down 0.8 %

Shares of NYSE:USPH opened at $76.90 on Thursday. U.S. Physical Therapy has a 52-week low of $76.18 and a 52-week high of $113.63. The business has a 50-day moving average price of $86.62 and a 200-day moving average price of $87.43. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The stock has a market cap of $1.17 billion, a price-to-earnings ratio of 81.80, a PEG ratio of 3.54 and a beta of 1.51.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing the consensus estimate of $0.69 by ($0.04). The business had revenue of $180.45 million during the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%.

U.S. Physical Therapy Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 14th will be given a dividend of $0.45 per share. The ex-dividend date of this dividend is Friday, March 14th. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.44. This represents a $1.80 dividend on an annualized basis and a yield of 2.34%. U.S. Physical Therapy’s payout ratio is presently 97.83%.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the business’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the transaction, the chief operating officer now directly owns 7,168 shares in the company, valued at $588,564.48. The trade was a 19.44 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On U.S. Physical Therapy

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. CBIZ Investment Advisory Services LLC increased its stake in U.S. Physical Therapy by 59.8% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock worth $29,000 after buying an additional 122 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new position in U.S. Physical Therapy in the fourth quarter valued at $39,000. Venturi Wealth Management LLC grew its stake in U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock worth $64,000 after purchasing an additional 704 shares in the last quarter. KBC Group NV increased its holdings in U.S. Physical Therapy by 68.6% during the 3rd quarter. KBC Group NV now owns 774 shares of the company’s stock worth $66,000 after purchasing an additional 315 shares during the period. Finally, Lazard Asset Management LLC acquired a new stake in U.S. Physical Therapy in the 4th quarter valued at about $84,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.